Refine
Has Fulltext
- yes (8)
Is part of the Bibliography
- yes (8)
Document Type
- Journal article (8)
Language
- English (8) (remove)
Keywords
- Cushing’s syndrome (2)
- B cell receptor (BCR) (1)
- BIRC7 (1)
- Burkitt lymphoma (1)
- Burkitt lymphoma (BL) (1)
- CTNNB1 (1)
- CXCR4 (1)
- Cushing’s disease (1)
- DOTATOC (1)
- Hypercortisolism (1)
- Immunosuppression (1)
- Kaposi sarcoma (1)
- NFATc1 (1)
- NR3C1 (1)
- PET/CT (1)
- PRRT (1)
- Positronen-Emissions-Tomografie (1)
- SSTR (1)
- Th17 (1)
- Tregs (1)
- USP8 (1)
- [\(^{68}\)Ga]Pentixafor (1)
- activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL) (1)
- adrenal tumor (1)
- adrenocortical (1)
- adrenocortical cancer (1)
- apoptosis (1)
- cancer (1)
- carcinoma metastases to pancreas (1)
- caspase-3 (1)
- chemokine receptor (1)
- cyclosporin A (1)
- glucocorticoid excess (1)
- hypercortisolism (1)
- immunohistochemistry (1)
- kinases (1)
- livin (1)
- methylation (1)
- neuroendocrine tumor (1)
- nuclear localization (1)
- peptide receptor radionuclide therapy (1)
- suppression (1)
- surgical treatment (1)
- systemic sclerosis (1)
Institute
- Pathologisches Institut (8) (remove)
EU-Project number / Contract (GA) number
- 701983 (1)
In Burkitt lymphoma (BL), a tumor of germinal center B cells, the pro-apoptotic properties of MYC are controlled by tonic B cell receptor (BCR) signals. Since BL cells do not exhibit constitutive NF-κB activity, we hypothesized that anti-apoptotic NFATc1 proteins provide a major transcriptional survival signal in BL. Here we show that post-transcriptional mechanisms are responsible for the calcineurin (CN) independent constitutive nuclear over-expression of NFATc1 in BL and Eµ-MYC – induced B cell lymphomas (BCL). Conditional inactivation of the Nfatc1 gene in B cells of Eµ-MYC mice leads to apoptosis of BCL cells in vivo and ex vivo. Inhibition of BCR/SYK/BTK/PI3K signals in BL cells results in cytosolic re-location of NFATc1 and apoptosis. Therefore, NFATc1 activity is an integrated part of tonic BCR signaling and an alternative target for therapeutic intervention in BL.